Cytonus Therapeutics, Inc. — Form D
Cytonus Therapeutics, Inc. of Carlsbad, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-18. The offering totals $5.0M, of which $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-03-18
- Form: D
- Accession: 0001761468-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.5M
- Remaining: $2.5M
- Investors: 1
- Date of first sale: 2021-03-05
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-392699
Issuer
- Name: Cytonus Therapeutics, Inc.
- CIK: 0001761468
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 3280 Grey Hawk Ct., Carlsbad, CA, 92010
- Phone: 631-258-4070
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Remo Moomiaie | Director | Carlsbad, CA |
| Remo Moomiaie | Executive Officer | Carlsbad, CA |
| Richard Klemke | Director | Carlsbad, CA |
| Richard Klemke | Executive Officer | Carlsbad, CA |
| Jae An | Director | Carlsbad, CA |
| Christopher Thorne | Director | Carlsbad, CA |
| Manisha Narasimhan | Director | Columbus, OH |
Other filings by this issuer (4)
More